Luca T.
- Country
- Italy
- Department
- 4104: Oncologia Medica ed Ematologia
Research Overview
- Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with Non-Small Cell Lung Cancer
- Phase 3 Randomized Double‑Blind Study of Adjuvant Taletrectinib Versus Placebo in Completely Resected Stage IB‑IIIA ROS1‑Fusion Positive Non‑Small Cell Lung Cancer
- Evaluation of Safety, Tolerability, and Efficacy of Volrustomig with Anticancer Agents in Patients with Solid Tumors: A Phase II Open-label Study
Data & Insights
Has run more than one trial at 224 of 438 partner sites.
Specializations
Non-Small Cell Lung Cancer
Specializes in investigating novel treatments for non-squamous non-small cell lung cancer across various stages and molecular profiles, with particular focus on early-stage disease and advanced metastatic cases.
- EGFR-Mutated NSCLC
- ALK-Positive NSCLC
- KRAS G12C-Positive NSCLC
Explores innovative therapeutic approaches including targeted therapies and immunotherapy combinations.
Specialized Lung Cancer Types
Conducts research in distinct lung cancer subtypes, including large-cell neuroendocrine carcinoma and small cell lung cancer.
- Metastatic LCNEC
- Relapsed SCLC
- Neuroendocrine Tumors
Evaluates novel treatment combinations and therapeutic strategies for rare lung cancer variants.
Treatment Approaches
Investigates multiple therapeutic modalities including immunotherapy, targeted therapies, and combination treatments.
- Neoadjuvant Therapy
- Adjuvant Treatment
- Maintenance Therapy
Focuses on personalized treatment strategies based on specific molecular and genetic markers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.